The Taiwanese vaccine maker, Medigen Vaccine Biologics Corp., said Tuesday that a World Health Organization-led (WHO) clinical trial of its COVID-19 vaccine could be unblinded in March at the earliest.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
TSMC founder honored for representing Taiwan at APEC
04/19/2024 10:21 PM - Cross-Strait
China to impose anti-dumping duties on Taiwan polycarbonate from Saturday
04/19/2024 10:07 PM - Business
Taiex registers record single-day drop
04/19/2024 08:43 PM - Cross-Strait
Taiwan protests China's expanded use of controversial flight paths
04/19/2024 08:19 PM - Politics
New minister of environment to roll out carbon pricing roadmap
04/19/2024 07:12 PM